Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments
Glioblastoma (GBM) is the most common form of brain tumor characterized by its resistance to conventional therapies, including temozolomide, the most widely used chemotherapeutic agent in the treatment of GBM. Within the tumor, the presence of glioma stem cells (GSC) seems to be the reason for drug...
Main Authors: | Ricardo Gómez-Oliva, Samuel Domínguez-García, Livia Carrascal, Jessica Abalos-Martínez, Ricardo Pardillo-Díaz, Cristina Verástegui, Carmen Castro, Pedro Nunez-Abades, Noelia Geribaldi-Doldán |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.614295/full |
Similar Items
-
Targeting Protein Kinase C in Glioblastoma Treatment
by: Noelia Geribaldi-Doldán, et al.
Published: (2021-04-01) -
Protein Kinase C: Targets to Regenerate Brain Injuries?
by: Noelia Geribaldi-Doldán, et al.
Published: (2019-03-01) -
Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment
by: Henry Ruiz-Garcia, et al.
Published: (2020-10-01) -
ADAM17/TACE: a key molecule in brain injury regeneration
by: Samuel Dominguez-Garcia, et al.
Published: (2019-01-01) -
Coaxially Bioprinted Cell-Laden Tubular-Like Structure for Studying Glioma Angiogenesis
by: Xuanzhi Wang, et al.
Published: (2021-10-01)